vs
Side-by-side financial comparison of Andersons, Inc. (ANDE) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
Andersons, Inc. is the larger business by last-quarter revenue ($329.5M vs $208.9M, roughly 1.6× iRhythm Holdings, Inc.). Andersons, Inc. runs the higher net margin — 20.5% vs 2.7%, a 17.8% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -2.4%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $-77.1M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -1.8%).
The Andersons, Inc. is an American agribusiness established in 1947, that began as Andersons Truck Terminal (ATT) in the 1940s for the grain industry, headquartered in Maumee, Ohio. It is a diversified company rooted in agriculture that conducts business in the commodity merchandising, renewables, and plant nutrient sectors.
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
ANDE vs IRTC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $329.5M | $208.9M |
| Net Profit | $67.4M | $5.6M |
| Gross Margin | 70.3% | 70.9% |
| Operating Margin | 26.6% | 1.1% |
| Net Margin | 20.5% | 2.7% |
| Revenue YoY | -2.4% | 27.1% |
| Net Profit YoY | 49.6% | 518.5% |
| EPS (diluted) | — | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $329.5M | $208.9M | ||
| Q3 25 | $295.8M | $192.9M | ||
| Q2 25 | $535.0M | $186.7M | ||
| Q1 25 | $370.8M | $158.7M | ||
| Q4 24 | $337.5M | $164.3M | ||
| Q3 24 | $231.9M | $147.5M | ||
| Q2 24 | $492.5M | $148.0M | ||
| Q1 24 | $341.4M | $131.9M |
| Q4 25 | $67.4M | $5.6M | ||
| Q3 25 | $20.1M | $-5.2M | ||
| Q2 25 | $7.9M | $-14.2M | ||
| Q1 25 | $284.0K | $-30.7M | ||
| Q4 24 | $45.1M | $-1.3M | ||
| Q3 24 | $27.4M | $-46.2M | ||
| Q2 24 | $36.0M | $-20.1M | ||
| Q1 24 | $5.6M | $-45.7M |
| Q4 25 | 70.3% | 70.9% | ||
| Q3 25 | 57.8% | 71.1% | ||
| Q2 25 | 29.6% | 71.2% | ||
| Q1 25 | 41.2% | 68.8% | ||
| Q4 24 | 63.1% | 70.0% | ||
| Q3 24 | 76.4% | 68.8% | ||
| Q2 24 | 35.6% | 69.9% | ||
| Q1 24 | 37.6% | 66.3% |
| Q4 25 | 26.6% | 1.1% | ||
| Q3 25 | 8.7% | -4.4% | ||
| Q2 25 | 4.6% | -10.0% | ||
| Q1 25 | 0.9% | -20.5% | ||
| Q4 24 | 19.9% | -2.5% | ||
| Q3 24 | 26.8% | -34.1% | ||
| Q2 24 | 11.6% | -15.5% | ||
| Q1 24 | 4.1% | -28.9% |
| Q4 25 | 20.5% | 2.7% | ||
| Q3 25 | 6.8% | -2.7% | ||
| Q2 25 | 1.5% | -7.6% | ||
| Q1 25 | 0.1% | -19.3% | ||
| Q4 24 | 13.4% | -0.8% | ||
| Q3 24 | 11.8% | -31.3% | ||
| Q2 24 | 7.3% | -13.6% | ||
| Q1 24 | 1.6% | -34.6% |
| Q4 25 | — | $0.18 | ||
| Q3 25 | $0.59 | $-0.16 | ||
| Q2 25 | $0.23 | $-0.44 | ||
| Q1 25 | $0.01 | $-0.97 | ||
| Q4 24 | $1.31 | $-0.03 | ||
| Q3 24 | $0.80 | $-1.48 | ||
| Q2 24 | $1.05 | $-0.65 | ||
| Q1 24 | $0.16 | $-1.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $98.3M | $583.8M |
| Total DebtLower is stronger | $560.0M | — |
| Stockholders' EquityBook value | $1.2B | $152.7M |
| Total Assets | $3.7B | $1.0B |
| Debt / EquityLower = less leverage | 0.45× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $98.3M | $583.8M | ||
| Q3 25 | — | $565.2M | ||
| Q2 25 | — | $545.5M | ||
| Q1 25 | — | $520.6M | ||
| Q4 24 | $561.8M | $535.6M | ||
| Q3 24 | — | $522.0M | ||
| Q2 24 | — | $561.5M | ||
| Q1 24 | — | $569.1M |
| Q4 25 | $560.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $608.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $152.7M | ||
| Q3 25 | $1.2B | $121.9M | ||
| Q2 25 | $1.4B | $103.7M | ||
| Q1 25 | $1.4B | $86.7M | ||
| Q4 24 | $1.4B | $90.9M | ||
| Q3 24 | $1.3B | $71.8M | ||
| Q2 24 | $1.3B | $99.2M | ||
| Q1 24 | $1.3B | $90.3M |
| Q4 25 | $3.7B | $1.0B | ||
| Q3 25 | $3.3B | $995.2M | ||
| Q2 25 | $3.4B | $964.0M | ||
| Q1 25 | $3.8B | $926.1M | ||
| Q4 24 | $4.1B | $931.4M | ||
| Q3 24 | $3.4B | $909.7M | ||
| Q2 24 | $3.3B | $919.2M | ||
| Q1 24 | $3.3B | $909.8M |
| Q4 25 | 0.45× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.2M | $26.2M |
| Free Cash FlowOCF − Capex | $-77.1M | $14.5M |
| FCF MarginFCF / Revenue | -23.4% | 6.9% |
| Capex IntensityCapex / Revenue | 21.5% | 5.6% |
| Cash ConversionOCF / Net Profit | -0.09× | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | $-56.1M | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.2M | $26.2M | ||
| Q3 25 | $233.9M | $34.9M | ||
| Q2 25 | $299.3M | $27.7M | ||
| Q1 25 | $-350.0M | $-7.9M | ||
| Q4 24 | $268.8M | $19.2M | ||
| Q3 24 | $-2.1M | $24.3M | ||
| Q2 24 | $304.4M | $11.8M | ||
| Q1 24 | $-239.6M | $-52.0M |
| Q4 25 | $-77.1M | $14.5M | ||
| Q3 25 | $167.0M | $20.1M | ||
| Q2 25 | $250.5M | $17.3M | ||
| Q1 25 | $-396.6M | $-17.3M | ||
| Q4 24 | $212.9M | $12.4M | ||
| Q3 24 | $-40.0M | $15.5M | ||
| Q2 24 | $275.8M | $3.4M | ||
| Q1 24 | $-266.4M | $-61.8M |
| Q4 25 | -23.4% | 6.9% | ||
| Q3 25 | 56.5% | 10.4% | ||
| Q2 25 | 46.8% | 9.3% | ||
| Q1 25 | -106.9% | -10.9% | ||
| Q4 24 | 63.1% | 7.5% | ||
| Q3 24 | -17.2% | 10.5% | ||
| Q2 24 | 56.0% | 2.3% | ||
| Q1 24 | -78.0% | -46.8% |
| Q4 25 | 21.5% | 5.6% | ||
| Q3 25 | 22.6% | 7.7% | ||
| Q2 25 | 9.1% | 5.6% | ||
| Q1 25 | 12.6% | 5.9% | ||
| Q4 24 | 16.6% | 4.2% | ||
| Q3 24 | 16.3% | 6.0% | ||
| Q2 24 | 5.8% | 5.7% | ||
| Q1 24 | 7.8% | 7.4% |
| Q4 25 | -0.09× | 4.70× | ||
| Q3 25 | 11.61× | — | ||
| Q2 25 | 38.10× | — | ||
| Q1 25 | -1232.46× | — | ||
| Q4 24 | 5.96× | — | ||
| Q3 24 | -0.08× | — | ||
| Q2 24 | 8.46× | — | ||
| Q1 24 | -42.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ANDE
| Specialty And Primary Nutrients | $137.1M | 42% |
| Premium Ingredients | $66.1M | 20% |
| Segment Reporting Reconciling Item Other | $63.2M | 19% |
| Other | $63.1M | 19% |
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
